Encompass Health Co. (NYSE:EHC) is 1492 Capital Management LLC’s 10th Largest Position

1492 Capital Management LLC cut its holdings in shares of Encompass Health Co. (NYSE:EHC) by 1.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 58,515 shares of the company’s stock after selling 575 shares during the quarter. Encompass Health comprises approximately 2.6% of 1492 Capital Management LLC’s portfolio, making the stock its 10th biggest holding. 1492 Capital Management LLC owned approximately 0.06% of Encompass Health worth $5,404,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in the business. Vanguard Group Inc. increased its holdings in shares of Encompass Health by 1.3% during the 4th quarter. Vanguard Group Inc. now owns 10,404,081 shares of the company’s stock worth $960,817,000 after buying an additional 138,196 shares during the last quarter. Invesco Ltd. increased its stake in Encompass Health by 3.3% during the fourth quarter. Invesco Ltd. now owns 5,536,251 shares of the company’s stock worth $511,273,000 after acquiring an additional 176,135 shares during the last quarter. Alliancebernstein L.P. increased its stake in Encompass Health by 6.0% during the fourth quarter. Alliancebernstein L.P. now owns 2,076,869 shares of the company’s stock worth $191,799,000 after acquiring an additional 117,617 shares during the last quarter. FMR LLC lifted its stake in shares of Encompass Health by 0.8% in the 4th quarter. FMR LLC now owns 1,973,846 shares of the company’s stock valued at $182,285,000 after purchasing an additional 15,831 shares in the last quarter. Finally, Geode Capital Management LLC grew its holdings in shares of Encompass Health by 0.4% during the 4th quarter. Geode Capital Management LLC now owns 1,679,774 shares of the company’s stock worth $155,176,000 after purchasing an additional 6,164 shares during the period. 97.25% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research analysts have weighed in on EHC shares. StockNews.com cut shares of Encompass Health from a “buy” rating to a “hold” rating in a research report on Wednesday. Barclays lifted their target price on shares of Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a report on Friday, February 7th. Royal Bank of Canada reiterated an “outperform” rating and issued a $110.00 price target on shares of Encompass Health in a report on Tuesday, February 11th. William Blair restated an “outperform” rating on shares of Encompass Health in a research note on Friday, February 7th. Finally, KeyCorp increased their target price on Encompass Health from $117.00 to $120.00 and gave the company an “overweight” rating in a research note on Monday, February 10th. One investment analyst has rated the stock with a hold rating, nine have given a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Buy” and a consensus price target of $107.67.

Insider Transactions at Encompass Health

In related news, CAO Andrew L. Price sold 5,042 shares of the firm’s stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total transaction of $495,578.18. Following the transaction, the chief accounting officer now directly owns 69,164 shares in the company, valued at $6,798,129.56. This trade represents a 6.79 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 2.10% of the company’s stock.

Encompass Health Price Performance

EHC stock opened at $103.53 on Friday. The stock’s 50 day moving average is $99.83 and its two-hundred day moving average is $98.19. Encompass Health Co. has a 52-week low of $78.53 and a 52-week high of $104.55. The company has a market capitalization of $10.43 billion, a PE ratio of 23.21, a P/E/G ratio of 2.31 and a beta of 0.87. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. Analysts predict that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st were paid a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 0.66%. The ex-dividend date of this dividend was Tuesday, April 1st. Encompass Health’s payout ratio is currently 15.25%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.